Medication for Opioid Use Disorder ECHO

Thinking about starting Medication for Opioid Use Disorder-buprenorphine treatment at your clinic? Have you started already and would like more guidance or support? This program is for you!

Using the ECHO Model, this program covers key aspects of prescribing with a focus on buprenorphine in clinic settings, including:

Overview of MOUD: induction, dosing, co-occurring disorders and special populations
Psychosocial supports: motivational interviewing, harm reduction, co-occurring disorders, etc.
Clinic-level resources and skills: screening, monitoring, workforce staffing, billing, etc.

This comprehensive curriculum was developed by The University of New Mexico Department of Psychiatry and Behavioral Sciences and UNM's Department of Family and Community Medicine. The core content is covered every three months.

Join Us

Our program meets every Tuesday, from noon to 1 p.m. Mountain Time.

Contact Us

For more information, contact our team.

Target Audience

Providers who are starting or expanding Medication for Opioid Use Disorder treatment

Providers who focus on rural primary care settings

Continuing Education Credits

We offer no-cost continuing education units, continuing medical education credits, and New Mexico Medical Board Pain Management hours.

Resources and Past Session Materials

Meet the Team

Julie G. Salvador, Ph.D.

Associate Professor, Department of Psychiatry and Behavioral Sciences, The University of New Mexico
Director of Implementation Science Mentorship, Department of Psychiatry and Behavioral Sciences, The University of New Mexico
Director of Team Science
Email Salvador

Snehal Bhatt, MD

Clinical Director for Behavioral Health Integration and Education, NM Bridge Project
Associate Professor, Department of Psychiatry and Behavioral Sciences, The University of New Mexico
Chief, Addiction Psychiatry, The University of New Mexico
Email Bhatt

Vanessa Jacobsohn, MD

Associate Professor, Department of Psychiatry and Behavioral Sciences, The University of New Mexico
Medical Director, Addiction and Substance Abuse Program (ASAP) Primary Care Clinic, The University of New Mexico
Attending Primary Care Physician, Addiction and Substance Abuse Program (ASAP) Primary Care Clinic, The University of New Mexico
Co-Educational Director and Presenter of ECHO-Facilitation to Expand MAT Treatment in Rural Primary Care

Larissa Lindsey, Ph.D.

Clinical pyschologist
Chief of Clinical Programming, Addiction and Substance Abuse Program (ASAP) Primary Care Clinic, The University of New Mexico

N. Patricia Fernandez, Ph.D. MPH

Clinical Psychologist
Psychology Manager for Addictions and Substance Abuse Program (ASAP), University Psychiatric Center Inpatient and Psychotherapy Clinic, The University of New Mexico Hospital
Training Coordinator of interdisciplinary therapy teams for Addictions and Substance Abuse Program (ASAP), University Psychiatric center Inpatient and Psychotherapy clinic, and Children’s Psychiatric Center, The University of New Mexico

Rachel Abeyta, BFA

Program Coordinator, State Opioid Response

Brandon Warrick, MD

Associate Professor with tenure, The University of New Mexico School of Medicine
Acting Medical Director of the New Mexico Poison and Drug Information Center
Board Certified in addiction medicine, medical toxicology and emergency medicine
Director for Statewide Infrastructure Development and Co-Director of Clinical Implementation, NM Bridge Project

Richard Gadomski, MD

Assistant Professor, Addiction Division, Department of Psychiatry and Behavioral Sciences
Board certified in preventive medicine

This ECHO program was developed with funding from the Agency for Healthcare Research and Quality.